Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MNPR compared with ADAG: revenue, margins and what each company keeps, and the suppliers and customers both name
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
ADAG
Adagene Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MNPR
Monopar Therapeutics
vs
ADAG
Adagene Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
MNPR
Report
implied
realized
× implied
Q2 FY26
—
▲
+0.38%
—
May 14 '26
—
▼
−0.73%
—
Q1 FY26
—
▼
−0.84%
—
Q3 FY25
—
▲
+5.36%
—
ADAG
No earnings history for ADAG.
= implied
MNPR realized, solid
ADAG realized, hatched
One scale, both sides: full bar = 6%
× = |realized| ÷ implied
Source: market data
MNPR
Monopar Therapeutics
Change
66.46
· pre 66.45
· delayed
Mkt cap
$444.9M
ADAG
Adagene Inc.
Change
2.25
· pre 2.25
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$118.9M
vs
Compare
Pre-market
Nov 2 '26
delayed
MNPR
Monopar Therapeutics
vs
ADAG
Adagene Inc.
66.46
pre 66.45
delayed
Price
2.25
pre 2.25
delayed
$444.9M
Mkt cap
$118.9M
Change
Change
MNPR
66.46
vs
ADAG
2.25
Pre-market
Nov 2 '26
delayed